How much does Tracr Hematology Limited make?

Tracr Hematology Limited reported revenue of £0 and £121k profit in the year to 31 Dec 2025, according to its accounts filed at Companies House.

How many employees does Tracr Hematology Limited have?

Tracr Hematology Limited reported an average of 0 employees in the year to 31 Dec 2025.

Is Tracr Hematology Limited profitable?

Yes — Tracr Hematology Limited reported a profit of £121k in the year to 31 Dec 2025.

Company No. 08859577 · Incorporated 23 Jan 2014

Tracr Hematology Limited

Registered name: TRACR HEMATOLOGY LIMITED

Part of Crispr Therapeautics Ag group

Tracr Hematology Limited made £0 revenue and £121k profit in the year to 31 Dec 2025.

Tracr Hematology Limited’s revenue was £0 in the year to 31 Dec 2025, with £121k profit and 0 employees. The company is classified under “research and experimental development on biotechnology” and is based in Ascot; we hold 4 years of its filed accounts.

Full P&L filedSection M · Professional, scientific and technical activitiesSIC 72110Research and experimental development on biotechnology

Status: Active
Location: Ascot, South East
Age: 12 yrs · since 2014
Type: Private Limited Company

Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2025

Key figures

Small team

Revenue

£0

Growth —

Profit

£121k

Growth —

Profit margin

—

Employees

Change —

Profit / employee

—

Profitable streak

1yr

Consecutive profitable years in our data

Unusual figures. Profit is higher than revenue in this filing. That usually means investment income, dividends from subsidiaries or one-off gains — or a mis-tagged figure. Check the original filing before drawing conclusions.

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2022	31 Dec 2023	31 Dec 2024	31 Dec 2025
Disclosure	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£0	£0	£0	£0
Profit before tax	−£385k	£68.9k	−£35.3k	£121k
Profit after tax	−£385k	£68.9k	−£35.3k	£121k
Profit (best available)	−£385k	£68.9k	−£35.3k	£121k
Employees (average)	0	0	0	0
Ratios
Profit margin	—	—	—	—
Growth (year on year)
Profit growth	—	—	▼151.3%	—
Balance sheet — indirect signals, not revenue
Net assets	−£2.8m	−£2.7m	−£2.8m	−£2.6m
Debtors	£6	£6	£6	£6
Source	FullAccounts · bulk data Oct 2024	FullAccounts · bulk data Oct 2024	FullAccounts · bulk data Dec 2025	FullAccounts · bulk data Sep 2026

Derived from the latest filing

How the business works

Profit margin: —; Profit ÷ revenue.
Gross margin: —; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: —; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: —; Now −£2.6m
Cash at bank: —; Now —
Headcount: —; Now 0
Deferred income: —; Now —
Fixed assets: —; Now —

Corporate ownership

Group structure

Ownership chain

Crispr Therapeautics Ag (registered outside the UK register)ultimate parent75–100%
Tracr Hematology Limitedthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £121k), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.